NeossONE™ – One Platform, Smart Prosthetics

NeossONE™ is a solution unique to the Neoss® Implant System – one prosthetic platform, across three implant ranges, including ALL implant diameters and abutments. Simply put, the same prosthetic components fit every implant.1

ONE Prosthetic Platform, ONE Impression Coping, ONE Kit!

One prosthetic platform, across three implant ranges, means one impression coping, one implant replica and one abutment interface, facilitating treatments that are adaptable and versatile. With fewer components in the system, complexity is reduced and time-efficiency is improved. All of which results in a truly cost-effective solution and predicable outcome.

Why Choose the NeossONE™ Platform?

In a market where simplicity is commonly claimed, Neoss® has redefined its meaning. In contrast to traditional implant systems necessitating up to a thousand components, Neoss® uses a minimum number of components to achieve the highest level of flexibility and functionality, without compromise. Utilizing NeossONE™, with its proven long-term clinical performance, enables integration of innovations in surgery and prosthetic rehabilitation, providing unique benefits for the whole dental team.

What does NeossONE™ Provide for the Dental Team?

For clinicians, it means predictable esthetics, soft tissue integration and prosthetic precision. The ingenuity lies not only in the NeossONE™ solution, but in the patented Neoss® implant design that optimizes stability in all bone qualities and conditions and eliminates the need for separate one- or two-stage designs. The benefits of both are clear: a predictable solution with shorter chair time2 and optimized inventory control.

“The NeossONE concept of a single restorative platform across an entire implant range is a huge benefit for our entire dental team. It offers elegant and comprehensive treatment solutions to achieve predictable long term results, whilst maintaining the simplicity of a reduced inventory.” Dr Kavit N Shah, BDS, MFDS.RCS (Eng), M.Clin.Dent, MRD.RCS (Eng), The London Centre for Prosthodontics.

For dental technicians, the NeossONE™ solution offers an intelligent and simple solution with less inventory of components, digital workflows supporting local production or central production for patient-specific solutions. This requires less effort and time to implement, gives maximum flexibility and strengthens relationships with the clinician’s team.

“I am probably one of the first customers of Neoss in the US (2006). I saw the ingenuity and technical advantages from the start, one prosthetic platform reduces inventory, eases communication and saves time.” Steven Pigliacelli, CDT, MDT, Marotta Dental Studio Inc.

The benefits are clear: reducing patient treatment time, optimizing inventory control and patient outcomes.

About Neoss®
Founded in 2000, by a professor of prosthodontists and a specialist engineer, Neoss® offers intelligent dental solutions that are intuitively simple to use. The company’s products are designed to allow dental professionals to provide reliable and cost-effective treatments to their patients with excellent long-term results. Leading with innovation and integrity, Neoss® develops smart treatment solutions and works closely with each practice to drive Intelligent Simplicity, making the complex less complicated. Headquartered in Harrogate, UK, with research and development based in Gothenburg, Sweden, the company has established a global footprint with long-standing presence in key markets.

To find out more about the NeossONE™ solution, visit or email

  1. Narrow diameter implant range excluded
  2. Customer feedback from the Neoss ProActive® Edge implant ambassador programme

NeossOneTM, Neoss® and Neoss ProActive® are trademarks and registered trademarks of Neoss Limited

Inaugural Osseointegration Day taking place this Monday – 3rd May

Neoss together with The Brånemark Osseointegration Center are proud to present the 1st annual Osseointegration Day on May 3rd, Professor Per-Ingvar Brånemark’s 92nd birthday.

The initiative was developed by Barbro K Brånemark together with the The Association of Brånemark Osseointegration Centers and Dr. Robert Gottlander, in tribute to Professor Per-Ingvar Brånemark and his innovations and inventions that continue to improve many lives around the world.

The principles of Osseointegration, a term founded by Professor Brånemark after his important breakthrough in the 1950s when he discovered that bone could integrate with titanium components, are the foundation for countless clinical applications.

Dr. Robert Gottlander, CEO of Neoss, said: “Barbro Brånemark and I are very pleased that the idea is now coming alive. Our intention is to have something every year to remember P-I and celebrate his birthday on May 3rd. We would not have been able to do this without the support from The American College of Prosthodontists (ACP), Dental Tribune International (DTI) and The European Association for Osseointegration (EAO). A special thanks to them.”

This year’s event will be a webinar where Professor Tomas Albrektsson, a long-time colleague and friend of Professor Brånemark, will give a presentation on Osseointegration and its fundamental significance for modern implant dentistry.

Registration is now open for the 1st Osseointegration Day and can be done here

About The Brånemark Osseointegration Center

The Brånemark Osseointegration Center (BOC) in Gothenburg, Sweden, was founded 1989. BOC’s primary mission was to provide treatment for patients with severe oral, maxillo-facial and orthopedic impediments. A thorough appreciation of tissue handling, biological processes and patient care have developed into fundamental principles, which together with specially designed components and instruments have come to be the basic concept of Osseointegration. For more information, please visit

CareCapital Acquires Neoss to Invest in Innovation

CareCapital Advisors Limited (“CareCapital”), an equity investor focused on the dental and oral care industry, today announced an agreement to acquire Neoss Limited (“Neoss”). CareCapital is one of the largest dental investors in the world, having invested more than US$1 billion in the sector, and provides a patient and collaborative environment for dental entrepreneurs and talented executives to realise their customer-centric visions. Neoss is a leading global dental implant company committed to designing intelligently simple solutions that provide reliable and cost-effective patient care with excellent long-term results. The Neoss brand is synonymous with innovation and quality, which has underpinned Neoss’ market leading performance in 2020 despite the coronavirus pandemic.

In conjunction with the transaction, Dr. Robert Gottlander has been appointed President and Chief Executive Officer of Neoss. With over forty years of dental industry experience, Gottlander has a proven track record developing and commercializing dental solutions.

Neoss Acquisition

Neoss has developed a range of market-leading dental solutions and “intelligently simple” procedures designed to deliver better patient care and shorter procedure times that enhance practice productivity. With a rich portfolio of intellectual property and long-term clinical data, Neoss’ peer-reviewed and published clinical support validates the efficacy of its solutions.

Dai Feng, Co-Founder and Managing Director of CareCapital, stated, “We are excited to welcome Neoss and Robert into our family. Both are dental trailblazers that, coupled, will elevate the Neoss customer experience and advance the Neoss mission. The company’s well–established brand, history of innovation, clinical validation and solid market position fit well with Robert’s customer-centric principles and passion for innovation.”

Michael J. Dormer, Chairman and CEO of Neoss, stated, “Reflecting on a wonderful journey over the past 20 years in which Neoss has built a formidable position in the dental marketplace, it is with great pride that our management team, staff and partners will be central to the next stage of progression under new ownership.”

Robert Gottlander Appointed Chief Executive Officer

After graduating from the University of Gothenburg School of Dentistry, Gottlander joined Nobel Biocare, where he held several senior executive leadership roles. Throughout his 27-year tenure, he led the team that established clinical and educational concepts for modern dental implantology, co-developed and launched Procera, the world’s first successful CADCAM system, and developed new concepts combining implants and digital dentistry. Gottlander then joined Henry Schein, Inc., where, as Chief Marketing Officer of Global Dental, he led the global initiative as strategic planner for prosthetic and implant solutions, guiding product offerings worldwide and creating commercial sales and marketing strategies. Gottlander went on to serve the dental industry on a consulting basis. Throughout his career, Gottlander has created numerous industry-university partnerships, architecting research projects and educational programs to improve dental implant and digital technology innovation.

After two decades of service, Dormer will retire, in line with his long-standing personal intentions. Dormer will remain with the company in an advisory role to ensure a smooth transition.

“I am thrilled to be joining the Neoss team,” asserted Dr. Gottlander. “Building on its esteemed heritage in Gothenburg, the birthplace of modern dental implants, Neoss shares my aspiration to pioneer dental innovation that improves patient care. I applaud the team at Neoss and Mr. Dormer for his leadership, who, together, have created a prominent global brand. I am looking forward to partnering with CareCapital to expand on that legacy and accelerate the long-term growth of the business through astute customer service and intelligently simple innovation.”

“I am excited to collaborate with CareCapital and Robert to further advance Neoss’ technology,” added Fredrik Engman, Co-Founder and Chief Technology Officer of Neoss. “The support and dental knowhow that this transaction brings, will benefit our staff to enable better service for the needs of doctors and patients.”